Loading
Latest filing published 11 May 2015 for TG Therapeutics, INC., €662k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by LFB Biotechnologies S.A.S.U. span 2 companies, the busiest being GTC Biotherapeutics Inc and TG Therapeutics, Inc. Between 3 January 2007 and 7 May 2015, the trades on record add up to 10 filings.
On the market, this insider has only ever bought: 4 purchases, €7.7M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. 2015 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €1.8M.
The record was last updated on 11 May 2015 with an open-market purchase (€662k) in TG Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations